A 2020 paper determined that approximately 2.8 million individuals around the globe suffer from multiple sclerosis (MS), an autoimmune disorder that damages the brain and spinal cord through immune system dysfunction. The exact causes of MS remain elusive, but a potential link has been discovered between MS and the Epstein-Barr virus (EBV).
Scientists from Sweden's Karolinska Institute have conducted further investigations into this association and have uncovered compelling evidence that antibodies designed to combat EBV can inadvertently contribute to the progression of MS.
Garry requires round the clock care for his complex needs as he suffers with Multiple Sclerosis and is considered in the high risk category during the current COVID-19 pandemic.
Antibodies Attacking the Nervous System
Symptoms of MS include fatigue, visual impairment, difficulties in mobility and balance, and cognitive impairment. While many people experience symptoms followed by recovery periods, the disease can eventually lead to permanent disability.
The 2022 study, titled "Longitudinal Analysis Reveals High Prevalence of Epstein-Barr Virus Associated With Multiple Sclerosis" published in Science, confirmed a strong association between the Epstein-Barr virus (EBV) and multiple sclerosis (MS). People with MS were found to have prior EBV infection, typically occurring several years before the onset of MS symptoms.
In healthy individuals, immune cells called T cells and B cells are responsible for fighting infections by generating antibodies that target specific pathogens.
However, in autoimmune diseases like MS, the immune system mistakenly attacks proteins within the body, a phenomenon known as molecular mimicry. According to Science Alert, this can result in a range of symptoms and diseases, with MS affecting the brain and spinal cord and causing neurological symptoms.
To gain further insight into this process, researchers analyzed blood samples from over 700 individuals with MS and a control group without the disease. They discovered that antibodies produced in response to a specific EBV protein called EBNA1 were elevated in MS patients.
Interestingly, these antibodies targeted a protein called alpha-crystallin B (Cryab), which is found in inflamed areas of the brain associated with MS. The study revealed that Cryab antibodies were present in up to 23% of MS patients compared to only 7% in the control group.
The findings suggest that the mistaken targeting of Cryab by EBNA1 antibodies could potentially contribute to the development or progression of MS in a significant portion of patients.
While the results provide important insights into the relationship between EBV and MS, there is considerable variation among individuals with the disease, suggesting that there may be different pathways leading to MS development. Previous research has also indicated that EBNA1 antibodies can bind to other proteins in the body, further supporting their involvement in MS.
READ ALSO: Does Cow Milk Exacerbate Symptoms of Multiple Sclerosis? Recent Study Discovers Mechanisms at Play
How Complicated is Multiple Sclerosis?
Dr. John Lindsey, a neurologist at McGovern Medical School at UTHealth in Houston, told Medical News Today that there is no evident immune system dysfunction in individuals with MS when compared to the general population. This suggests that MS involves an unusual immune response triggered by an unknown stimulus, leading to the immune system attacking the brain and spinal cord.
Moreover, predicting the course of MS is challenging due to the wide range of effects it can have, varying from mild to severe. Lindsey explains that individuals diagnosed with MS can experience vastly different outcomes.
Some may experience a rapid and aggressive progression of the disease, resulting in disability within a few years, while others may have a more benign course characterized by occasional symptoms but no significant disability.
The complex nature of MS, with its elusive causes and unpredictable outcomes, continues to pose a challenge for researchers and healthcare professionals seeking to better understand and manage the disease. Further research is needed to unravel the underlying mechanisms and develop more effective strategies for treatment and personalized care.
RELATED ARTICLE: Teenagers Who Catch the "Kissing Disease" Increases Risk of Developing Multiple Sclerosis Later in Life
Check out more news and information on Multiple Sclerosis in Science Times.
